Clinical Trial Update: A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial entry for SCTC21C in systemic lupus erythematosus, a Phase 1/2 study that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SCTC21C

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING